{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T07:40:08Z","timestamp":1791272408173,"version":"4.1.0"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2011,10,20]],"date-time":"2011-10-20T00:00:00Z","timestamp":1319068800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Acta Neuropathol"],"published-print":{"date-parts":[[2012,2]]},"DOI":"10.1007\/s00401-011-0887-y","type":"journal-article","created":{"date-parts":[[2011,10,19]],"date-time":"2011-10-19T02:20:46Z","timestamp":1318990846000},"page":"223-233","source":"Crossref","is-referenced-by-count":185,"title":["Immunohistochemical testing of BRAF V600E status in 1,120 tumor tissue samples of patients with brain metastases"],"prefix":"10.1007","volume":"123","author":[{"given":"David","family":"Capper","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna Sophie","family":"Berghoff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuel","family":"Magerle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayseg\u00fcl","family":"Ilhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adelheid","family":"W\u00f6hrer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monika","family":"Hackl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josef","family":"Pichler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Pusch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jochen","family":"Meyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antje","family":"Habel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Petzelbauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Birner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"von Deimling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias","family":"Preusser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2011,10,20]]},"reference":[{"key":"887_CR1","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.jmoldx.2010.11.005","volume":"13","author":"M Arcila","year":"2011","unstructured":"Arcila M, Lau C, Nafa K, Ladanyi M (2011) Detection of KRAS and BRAF mutations in colorectal carcinoma roles for high-sensitivity locked nucleic acid-PCR sequencing and broad-spectrum mass spectrometry genotyping. J Mol Diagn 13:64\u201373","journal-title":"J Mol Diagn"},{"key":"887_CR2","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/s00401-011-0841-z","volume":"122","author":"D Capper","year":"2011","unstructured":"Capper D, Preusser M, Habel A et al (2011) Assessment of BRAF V600E mutation status by immunohistochemistry with a mutation-specific monoclonal antibody. Acta Neuropathol 122:11\u201319","journal-title":"Acta Neuropathol"},{"key":"887_CR3","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1111\/j.1750-3639.2009.00352.x","volume":"20","author":"D Capper","year":"2010","unstructured":"Capper D, Weissert S, Balss J et al (2010) Characterization of R132H mutation-specific IDH1 antibody binding in brain tumors. Brain Pathol 20:245\u2013254","journal-title":"Brain Pathol"},{"key":"887_CR4","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1007\/s00401-009-0595-z","volume":"118","author":"D Capper","year":"2009","unstructured":"Capper D, Zentgraf H, Balss J, Hartmann C, von Deimling A (2009) Monoclonal antibody specific for IDH1 R132H mutation. Acta Neuropathol 118:599\u2013601","journal-title":"Acta Neuropathol"},{"key":"887_CR5","doi-asserted-by":"crossref","first-page":"2507","DOI":"10.1056\/NEJMoa1103782","volume":"364","author":"PB Chapman","year":"2011","unstructured":"Chapman PB, Hauschild A, Robert C et al (2011) Improved survival with vemurafenib in melanoma with BRAF V600E mutation. N Engl J Med 364:2507\u20132516","journal-title":"N Engl J Med"},{"key":"887_CR6","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1097\/01.cmr.0000232300.22032.86","volume":"16","author":"E Edlundh-Rose","year":"2006","unstructured":"Edlundh-Rose E, Egyhazi S, Omholt K et al (2006) NRAS and BRAF mutations in melanoma tumours in relation to clinical characteristics: a study based on mutation screening by pyrosequencing. Melanoma Res 16:471\u2013478","journal-title":"Melanoma Res"},{"key":"887_CR7","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1056\/NEJMoa1002011","volume":"363","author":"KT Flaherty","year":"2010","unstructured":"Flaherty KT, Puzanov I, Kim KB et al (2010) Inhibition of mutated, activated BRAF in metastatic melanoma. N Engl J Med 363:809\u2013819","journal-title":"N Engl J Med"},{"key":"887_CR8","doi-asserted-by":"crossref","unstructured":"Forbes SA, Bhamra G, Bamford S et al (2008) The catalogue of somatic mutations in cancer (COSMIC). Curr Protoc Hum Genet Chapter 10:Unit 10 11","DOI":"10.1002\/0471142905.hg1011s57"},{"key":"887_CR9","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1055\/s-0030-1255225","volume":"30","author":"FG Kamar","year":"2010","unstructured":"Kamar FG, Posner JB (2010) Brain metastases. Semin Neurol 30:217\u2013235","journal-title":"Semin Neurol"},{"key":"887_CR10","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1586\/era.10.165","volume":"10","author":"Y Kienast","year":"2010","unstructured":"Kienast Y, Winkler F (2010) Therapy and prophylaxis of brain metastases. Expert Rev Anticancer Ther 10:1763\u20131777","journal-title":"Expert Rev Anticancer Ther"},{"key":"887_CR11","first-page":"1454","volume":"63","author":"ET Kimura","year":"2003","unstructured":"Kimura ET, Nikiforova MN, Zhu Z, Knauf JA, Nikiforov YE, Fagin JA (2003) High prevalence of BRAF mutations in thyroid cancer: genetic evidence for constitutive activation of the RET\/PTC-RAS-BRAF signaling pathway in papillary thyroid carcinoma. Cancer Res 63:1454\u20131457","journal-title":"Cancer Res"},{"key":"887_CR12","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1007\/s00401-009-0611-3","volume":"119","author":"HV K\u00fcsters-Vandevelde","year":"2010","unstructured":"K\u00fcsters-Vandevelde HV, Klaasen A, Kusters B et al (2010) Activating mutations of the GNAQ gene: a frequent event in primary melanocytic neoplasms of the central nervous system. Acta Neuropathol 119:317\u2013323","journal-title":"Acta Neuropathol"},{"key":"887_CR13","unstructured":"Long GV, Kefford RF, Carr PJA et al (2010) Phase 1\/2 study of GSK2118436, a selective inhibitor of V600 mutant BRAF kinase: evidence of activity in melanoma brain metastases. Ann Oncol LBA27"},{"key":"887_CR14","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1200\/JCO.2010.32.4327","volume":"29","author":"GV Long","year":"2011","unstructured":"Long GV, Menzies AM, Nagrial AM et al (2011) Prognostic and clinicopathologic associations of oncogenic BRAF in metastatic melanoma. J Clin Oncol 29:1239\u20131246","journal-title":"J Clin Oncol"},{"key":"887_CR15","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/j.jmoldx.2011.05.010","volume":"13","author":"S Magnin","year":"2011","unstructured":"Magnin S, Viel E, Baraquin A et al (2011) A multiplex SNaPshot assay as a rapid method for detecting KRAS and BRAF mutations in advanced colorectal cancers. J Mol Diagn 13:485\u2013492","journal-title":"J Mol Diagn"},{"key":"887_CR16","doi-asserted-by":"crossref","first-page":"2046","DOI":"10.1200\/JCO.2010.33.1280","volume":"29","author":"PK Paik","year":"2011","unstructured":"Paik PK, Arcila ME, Fara M et al (2011) Clinical characteristics of patients with lung adenocarcinomas harboring BRAF mutations. J Clin Oncol 29:2046\u20132051","journal-title":"J Clin Oncol"},{"key":"887_CR17","doi-asserted-by":"crossref","unstructured":"Papadatos-Pastos D, Banerji U (2011) Revisiting the role of molecular targeted therapies in patients with brain metastases. J Neurooncol ISSN: 1573\u20137373","DOI":"10.1007\/s11060-011-0661-y"},{"key":"887_CR18","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.molonc.2007.12.003","volume":"1","author":"A Platz","year":"2008","unstructured":"Platz A, Egyhazi S, Ringborg U, Hansson J (2008) Human cutaneous melanoma; a review of NRAS and BRAF mutation frequencies in relation to histogenetic subclass and body site. Mol Oncol 1:395\u2013405","journal-title":"Mol Oncol"},{"key":"887_CR19","doi-asserted-by":"crossref","unstructured":"Preusser M, Capper D, Hartmann C (2011) IDH testing in diagnostic neuropathology: review and practical guideline article invited by the Euro-CNS research committee. Clin Neuropathol (in press)","DOI":"10.5414\/NP300422"},{"key":"887_CR20","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1097\/NEN.0b013e31822713f0","volume":"70","author":"M Preusser","year":"2011","unstructured":"Preusser M, Wohrer A, Stary S, Hoftberger R, Streubel B, Hainfellner JA (2011) Value and limitations of immunohistochemistry and gene sequencing for detection of the IDH1\u2013R132H mutation in diffuse glioma biopsy specimens. J Neuropathol Exp Neurol 70:715\u2013723","journal-title":"J Neuropathol Exp Neurol"},{"key":"887_CR21","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1007\/s00401-011-0802-6","volume":"121","author":"G Schindler","year":"2011","unstructured":"Schindler G, Capper D, Meyer J et al (2011) Analysis of BRAF V600E mutation in 1, 320 nervous system tumors reveals high mutation frequencies in pleomorphic xanthoastrocytoma, ganglioglioma and extra-cerebellar pilocytic astrocytoma. Acta Neuropathol 121:397\u2013405","journal-title":"Acta Neuropathol"},{"key":"887_CR22","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1093\/jnci\/95.6.484","volume":"95","author":"G Singer","year":"2003","unstructured":"Singer G, Oldt R 3rd, Cohen Y et al (2003) Mutations in BRAF and KRAS characterize the development of low-grade ovarian serous carcinoma. J Natl Cancer Inst 95:484\u2013486","journal-title":"J Natl Cancer Inst"},{"key":"887_CR23","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1136\/gut.52.5.706","volume":"52","author":"A Tannapfel","year":"2003","unstructured":"Tannapfel A, Sommerer F, Benicke M et al (2003) Mutations of the BRAF gene in cholangiocarcinoma but not in hepatocellular carcinoma. Gut 52:706\u2013712","journal-title":"Gut"},{"key":"887_CR24","doi-asserted-by":"crossref","first-page":"2305","DOI":"10.1056\/NEJMoa1014209","volume":"364","author":"E Tiacci","year":"2011","unstructured":"Tiacci E, Trifonov V, Schiavoni G et al (2011) BRAF mutations in hairy-cell leukemia. N Engl J Med 364:2305\u20132315","journal-title":"N Engl J Med"},{"key":"887_CR25","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.1158\/1078-0432.CCR-10-0174","volume":"17","author":"A Vultur","year":"2011","unstructured":"Vultur A, Villanueva J, Herlyn M (2011) Targeting BRAF in advanced melanoma: a first step toward manageable disease. Clin Cancer Res 17:1658\u20131663","journal-title":"Clin Cancer Res"},{"key":"887_CR26","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1016\/S0092-8674(04)00215-6","volume":"116","author":"PT Wan","year":"2004","unstructured":"Wan PT, Garnett MJ, Roe SM et al (2004) Mechanism of activation of the RAF-ERK signaling pathway by oncogenic mutations of B-RAF. Cell 116:855\u2013867","journal-title":"Cell"},{"key":"887_CR27","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1007\/s11060-009-9938-9","volume":"95","author":"A Wohrer","year":"2009","unstructured":"Wohrer A, Waldhor T, Heinzl H et al (2009) The Austrian brain tumour registry: a cooperative way to establish a population-based brain tumour registry. J Neurooncol 95:401\u2013411","journal-title":"J Neurooncol"},{"key":"887_CR28","first-page":"6451","volume":"62","author":"ST Yuen","year":"2002","unstructured":"Yuen ST, Davies H, Chan TL et al (2002) Similarity of the phenotypic patterns associated with BRAF and KRAS mutations in colorectal neoplasia. Cancer Res 62:6451\u20136455","journal-title":"Cancer Res"}],"container-title":["Acta Neuropathologica"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00401-011-0887-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00401-011-0887-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00401-011-0887-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,17]],"date-time":"2019-06-17T22:47:24Z","timestamp":1560811644000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00401-011-0887-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,10,20]]},"references-count":28,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2012,2]]}},"alternative-id":["887"],"URL":"https:\/\/doi.org\/10.1007\/s00401-011-0887-y","relation":{},"ISSN":["0001-6322","1432-0533"],"issn-type":[{"value":"0001-6322","type":"print"},{"value":"1432-0533","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,10,20]]}}}